PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

Journal of Experimental Medicine

Volumn 206, Issue 13, 2009, Pages 3015-3029

  Francisco, Loise M ^a,b   Salinas, Victor H ^c   Brown, Keturah E ^a   Vanguri, Vijay K ^a,b   Freeman, Gordon J ^d   Kuchroo, Vijay K ^b   Sharpe, Arlene H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGRAMMED DEATH 1 LIGAND; PROTEIN KINASE B; S6 KINASE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; B7 ANTIGEN; CARRIER PROTEIN; CD45 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; FRAP1 PROTEIN, MOUSE; MEMBRANE PROTEIN; PDCD1LG1 PROTEIN, MOUSE; PDCD1LG2 PROTEIN, MOUSE; PEPTIDE; PHOSPHOTRANSFERASE; PTPRC PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GROWTH REGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INDUCED REGULATORY T LYMPHOCYTE; INFLAMMATION; LYMPHOCYTE TRANSFORMATION; MALE; MOUSE; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; C57BL MOUSE; LUNG; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD45; ANTIGENS, CD80; CARRIER PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; LUNG; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PEPTIDES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 73949088551     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20090847     Document Type: Article

References (76)

1. Adler, H.S., S. Kubsch, E. Graulich, S. Ludwig, J. Knop, and K. Steinbrink. 2007. Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells. Blood. 109:4351-4359. doi:10.1182/blood-2006-09-047563
2. Baecher-Allan, C., J.A. Brown, G.J. Freeman, and D.A. Hafler. 2003. CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. Novartis Found. Symp. 252:67-88, discussion :88-91: 106-114. doi:10.1002/0470871628.ch6
3. Barber, D.L., E.J. Wherry, D. Masopust, B. Zhu, J.P. Allison, A.H. Sharpe, G.J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 439:682-687. doi:10.1038/ nature04444
4. Battaglia, M., A. Stabilini, B. Migliavacca, J. Horejs-Hoeck, T. Kaupper, and M.G. Roncarolo. 2006. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177:8338-8347.
5. Belkaid, Y. 2008. Role of Foxp3-positive regulatory T cells during infection. Eur. J. Immunol. 38:918-921. doi:10.1002/eji.200738120
6. Beswick, E.J., I.V. Pinchuk, S. Das, D.W. Powell, and V.E. Reyes. 2007. Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells. Infect. Immun. 75:4334-4341. doi:10 .1128/IAI.00553-07
7. Bettelli, E., M. Pagany, H.L. Weiner, C. Linington, R.A. Sobel, and V.K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197:1073-1081. doi:10.1084/jem.20021603
8. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441:235-238. doi:10.1038/nature04753
9. Blank, C., T.F. Gajewski, and A. Mackensen. 2005. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol. Immunother. 54:307-314. doi:10.1007/s00262-004-0593-x
10. Bloom, D.D., Z. Chang, J.H. Fechner, W. Dar, S.P. Polster, J. Pascual, L.A. Turka, and S.J. Knechtle. 2008. CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. Am. J. Transplant. 8:793-802. doi:10.1111/j.1600-6143.2007. 02134.x
11. Broeren, C.P., G.S. Gray, B.M. Carreno, and C.H. June. 2000. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile. J. Immunol. 165:6908-6914.
12. Brown, J.A., D.M. Dorfman, F.R. Ma, E.L. Sullivan, O. Munoz, C.R. Wood, E.A. Greenfield, and G.J. Freeman. 2003. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170:1257-1266.
13. Brunkow, M.E., E.W. Jeffery, K.A. Hjerrild, B. Paeper, L.B. Clark, S.A. Yasayko, J.E. Wilkinson, D. Galas, S.F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68-73. doi:10.1038/83784
14. Calzascia, T., M. Pellegrini, A. Lin, K.M. Garza, A.R. Elford, A. Shahinian, P.S. Ohashi, and T.W. Mak. 2008. CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc. Natl. Acad. Sci. USA. 105:2999-3004. doi:10.1073/pnas.0712135105
15. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198:1875-1886. doi:10.1084/jem.20030152
16. Clark, L.B., M.W. Appleby, M.E. Brunkow, J.E. Wilkinson, S.F. Ziegler, and F. Ramsdell. 1999. Cellular and molecular characterization of the scurfy mouse mutant. J. Immunol. 162:2546-2554.
17. Coenen, J.J., H.J. Koenen, E. van Rijssen, A. Kasran, L. Boon, L.B. Hilbrands, and I. Joosten. 2007. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells. Bone Marrow Transplant. 39:537-545. doi:10.1038/sj.bmt.1705628
18. Collison, L.W., C.J. Workman, T.T. Kuo, K. Boyd, Y. Wang, K.M. Vignali, R. Cross, D. Sehy, R.S. Blumberg, and D.A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 450:566-569. doi:10.1038/nature06306
19. + regulatory T cells via a TGF-β- and retinoic acid-dependent mechanism. J. Exp. Med. 204:1757-1764. doi:10.1084/jem.20070590
20. Das, S., G. Suarez, E.J. Beswick, J.C. Sierra, D.Y. Graham, and V.E. Reyes. 2006. Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J. Immunol. 176:3000-3009.
21. Dong, H., S.E. Strome, D.R. Salomao, H. Tamura, F. Hirano, D.B. Flies, P.C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8:793-800.
22. Dorfman, D.M., J.A. Brown, A. Shahsafaei, and G.J. Freeman. 2006. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am. J. Surg. Pathol. 30:802-810. doi:10.1097/01.pas.0000209855.28282.ce
23. Fantini, M.C., C. Becker, G. Monteleone, F. Pallone, P.R. Galle, and M.F. Neurath. 2004. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172:5149-5153.
24. Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-336. doi:10.1038/ni904
25. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329-341. doi:10.1016/j.immuni. 2005.01.016
26. Gao, W., Y. Lu, B. El Essawy, M. Oukka, V.K. Kuchroo, and T.B. Strom. 2007. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am. J. Transplant. 7:1722-1732. doi:10.1111/j.1600-6143.2007.01842.x
27. Gavin, M.A., J.P. Rasmussen, J.D. Fontenot, V. Vasta, V.C. Manganiello, J.A. Beavo, and A.Y. Rudensky. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 445:771-775. doi:10.1038/nature05543
28. + cells. J. Exp. Med. 205:565-574. doi:10.1084/jem.20071477
29. Hill, J.A., M. Feuerer, K. Tash, S. Haxhinasto, J. Perez, R. Melamed, D. Mathis, and C. Benoist. 2007. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity. 27:786-800. doi:10.1016/j.immuni.2007.09.010
30. Hirano, F., K. Kaneko, H. Tamura, H. Dong, S. Wang, M. Ichikawa, C. Rietz, D.B. Flies, J.S. Lau, G. Zhu, et al. 2005. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res. 65:1089-1096.
31. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061. doi:10.1126/science.1079490
32. Huber, S., J. Schrader, G. Fritz, K. Presser, S. Schmitt, A. Waisman, S. Lüth, M. Blessing, J. Herkel, and C. Schramm. 2008. P38 MAP kinase signaling is required for the conversion of CD4+CD25- T cells into iTreg. PLoS One. 3:e3302. doi:10.1371/journal.pone.0003302
33. Inman, B.A., T.J. Sebo, X. Frigola, H. Dong, E.J. Bergstralh, I. Frank, Y. Fradet, L. Lacombe, and E.D. Kwon. 2007. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer. 109:1499-1505. doi:10.1002/cncr.22588
34. Iwai, Y., M. Ishida, Y. Tanaka, T. Okazaki, T. Honjo, and N. Minato. 2002. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. USA. 99:12293-12297. doi:10.1073/pnas.192461099
35. Joetham, A., S. Matsubara, M. Okamoto, K. Takeda, N. Miyahara, A. Dakhama, and E.W. Gelfand. 2008. Plasticity of regulatory T cells: subversion of suppressive function and conversion to enhancement of lung allergic responses. J. Immunol. 180:7117-7124.
36. Keir, M.E., S.C. Liang, I. Guleria, Y.E. Latchman, A. Qipo, L.A. Albacker, M. Koulmanda, G.J. Freeman, M.H. Sayegh, and A.H. Sharpe. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203:883-895. doi:10.1084/jem.20051776
37. Keir, M.E., L.M. Francisco, and A.H. Sharpe. 2007a. PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 19:309-314. doi:10.1016/j.coi. 2007.04.012
38. Keir, M.E., G.J. Freeman, and A.H. Sharpe. 2007b. PD-1 regulates selfreactive CD8+ T cell responses to antigen in lymph nodes and tissues. J. Immunol. 179:5064-5070.
39. Keir, M.E., M.J. Butte, G.J. Freeman, and A.H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26:677-704. doi:10.1146/annurev.immunol.26.021607.090331
40. Kim, J.M., J.P. Rasmussen, and A.Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8:191-197. doi:10.1038/ni1428
41. Konishi, J., K. Yamazaki, M. Azuma, I. Kinoshita, H. Dosaka-Akita, and M. Nishimura. 2004. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin. Cancer Res. 10:5094-5100. doi:10.1158/1078-0432.CCR-04-0428
42. Kronenberg, M., and A. Rudensky. 2005. Regulation of immunity by selfreactive T cells. Nature. 435:598-604. doi:10.1038/nature03725
43. Krupnick, A.S., A.E. Gelman, W. Barchet, S. Richardson, F.H. Kreisel, L.A. Turka, M. Colonna, G.A. Patterson, and D. Kreisel. 2005. Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J. Immunol. 175:6265-6270.
44. Latchman, Y.E., S.C. Liang, Y. Wu, T. Chernova, R.A. Sobel, M. Klemm, V.K. Kuchroo, G.J. Freeman, and A.H. Sharpe. 2004. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. USA. 101:10691-10696. doi:10.1073/pnas.0307252101
45. + regulatory T cells in vivo requires B7 costimulation, but not the thymus. J. Exp. Med. 201:127-137. doi:10.1084/jem.20041201
46. Lin, W., D. Haribhai, L.M. Relland, N. Truong, M.R. Carlson, C.B. Williams, and T.A. Chatila. 2007. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8:359-368. doi:10.1038/ni1445
47. Lohr, J., B. Knoechel, and A.K. Abbas. 2006. Regulatory T cells in the periphery. Immunol. Rev. 212:149-162. doi:10.1111/j.0105-2896.2006.00414. x
48. Long, S.A., and J.H. Buckner. 2008. Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells. J. Autoimmun. 30:293-302. doi:10.1016/j.jaut.2007.12.012
49. Luo, X., Q. Zhang, V. Liu, Z. Xia, K.L. Pothoven, and C. Lee. 2008. Cutting edge: TGF-beta-induced expression of Foxp3 in T cells is mediated through inactivation of ERK. J. Immunol. 180:2757-2761.
50. + regulatory T cells. J. Exp. Med. 201:1061-1067. doi:10.1084/jem.20042276
51. Nakanishi, J., Y. Wada, K. Matsumoto, M. Azuma, K. Kikuchi, and S. Ueda. 2007. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers. Cancer Immunol. Immunother. 56:1173-1182. doi:10.1007/s00262-006-0266-z
52. Nomi, T., M. Sho, T. Akahori, K. Hamada, A. Kubo, H. Kanehiro, S. Nakamura, K. Enomoto, H. Yagita, M. Azuma, and Y. Nakajima. 2007. Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. Clin. Cancer Res. 13:2151-2157. doi:10.1158/1078-0432.CCR-06-2746
53. Ohigashi, Y., M. Sho, Y. Yamada, Y. Tsurui, K. Hamada, N. Ikeda, T. Mizuno, R. Yoriki, H. Kashizuka, K. Yane, et al. 2005. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin. Cancer Res. 11:2947-2953. doi:10.1158/1078-0432. CCR-04-1469
54. Probst, H.C., K. McCoy, T. Okazaki, T. Honjo, and M. van den Broek. 2005. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6:280-286. doi:10.1038/ni1165
55. Pyzik, M., and C.A. Piccirillo. 2007. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets. J. Leukoc. Biol. 82:335-346. doi:10.1189/jlb.1006644
56. Qu, Y., B. Zhang, L. Zhao, G. Liu, H. Ma, E. Rao, C. Zeng, and Y. Zhao. 2007. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Transpl. Immunol. 17:153-161. doi:10.1016/j.trim.2007.01.002
57. Ramsdell, F. 2003. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity. 19:165-168. doi:10.1016/S1074-7613(03)00207-3
58. Riley, J.L., M. Mao, S. Kobayashi, M. Biery, J. Burchard, G. Cavet, B.P. Gregson, C.H. June, and P.S. Linsley. 2002. Modulation of TCRinduced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl. Acad. Sci. USA. 99:11790-11795. doi:10.1073/pnas.162359999
59. Roncarolo, M.G., and M. Battaglia. 2007. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 7:585-598. doi:10.1038/nri2138
60. Rubtsov, Y.P., and A.Y. Rudensky. 2007. TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat. Rev. Immunol. 7:443-453. doi:10.1038/nri2095
61. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell. 133:775-787. doi:10.1016/j.cell.2008. 05.009
62. Sauer, S., L. Bruno, A. Hertweck, D. Finlay, M. Leleu, M. Spivakov, Z.A. Knight, B.S. Cobb, D. Cantrell, E. O'Connor, et al. 2008. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA. 105:7797-7802. doi:10.1073/pnas.0800928105
63. Schubert, L.A., E. Jeffery, Y. Zhang, F. Ramsdell, and S.F. Ziegler. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276:37672-37679. doi:10.1074/jbc.M104521200
64. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201:723-735. doi:10.1084/jem.20041982
65. Sharpe, A.H., E.J. Wherry, R. Ahmed, and G.J. Freeman. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8:239-245. doi:10.1038/ni1443
66. Strauss, L., T.L. Whiteside, A. Knights, C. Bergmann, A. Knuth, and A. Zippelius. 2007. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J. Immunol. 178:320-329.
67. Strome, S.E., H. Dong, H. Tamura, S.G. Voss, D.B. Flies, K. Tamada, D. Salomao, J. Cheville, F. Hirano, W. Lin, et al. 2003. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res. 63:6501-6505.
68. Tang, Q., and J.A. Bluestone. 2008. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9:239-244. doi:10.1038/ni1572
69. Tang, Q., K.J. Henriksen, E.K. Boden, A.J. Tooley, J. Ye, S.K. Subudhi, X.X. Zheng, T.B. Strom, and J.A. Bluestone. 2003. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol. 171:3348-3352.
70. Thompson, R.H., M.D. Gillett, J.C. Cheville, C.M. Lohse, H. Dong, W.S. Webster, K.G. Krejci, J.R. Lobo, S. Sengupta, L. Chen, et al. 2004. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc. Natl. Acad. Sci. USA. 101:17174-17179. doi:10.1073/pnas.0406351101
71. Vignali, D.A., L.W. Collison, and C.J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8:523-532. doi:10.1038/nri2343
72. Williams, L.M., and A.Y. Rudensky. 2007. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8:277-284. doi:10.1038/ni1437
73. Winstead, C.J., J.M. Fraser, and A. Khoruts. 2008. Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells. J. Immunol. 180:7305-7317.
74. Wu, C., Y. Zhu, J. Jiang, J. Zhao, X.G. Zhang, and N. Xu. 2006. Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. Acta Histochem. 108:19-24. doi:10.1016/j.acthis.2006.01.003
75. Yang, X.O., R. Nurieva, G.J. Martinez, H.S. Kang, Y. Chung, B.P. Pappu, B. Shah, S.H. Chang, K.S. Schluns, S.S. Watowich, et al. 2008. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 29:44-56. doi:10.1016/j.immuni.2008.05.007
76. Zhang, P., D.M. Su, M. Liang, and J. Fu. 2008. Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis. Mol. Immunol. 45:1470-1476. doi:10.1016/j.molimm.2007.08.013